Annual EBITDA
-$12.36 M
+$1.29 M+9.42%
December 1, 2023
Summary
- As of February 8, 2025, KPRX annual EBITDA is -$12.36 million, with the most recent change of +$1.29 million (+9.42%) on December 1, 2023.
- During the last 3 years, KPRX annual EBITDA has fallen by -$5.55 million (-81.45%).
- KPRX annual EBITDA is now -1015.48% below its all-time high of -$1.11 million, reached on December 31, 2014.
Performance
KPRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.70 M
-$277.80 K-11.49%
September 1, 2024
Summary
- As of February 8, 2025, KPRX quarterly EBITDA is -$2.70 million, with the most recent change of -$277.80 thousand (-11.49%) on September 1, 2024.
- Over the past year, KPRX quarterly EBITDA has dropped by -$206.60 thousand (-8.30%).
- KPRX quarterly EBITDA is now -120.40% below its all-time high of $13.21 million, reached on March 1, 2024.
Performance
KPRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$2.39 M
-$206.60 K-7.94%
September 1, 2024
Summary
- As of February 8, 2025, KPRX TTM EBITDA is $2.39 million, with the most recent change of -$206.60 thousand (-7.94%) on September 1, 2024.
- Over the past year, KPRX TTM EBITDA has increased by +$14.62 million (+119.58%).
- KPRX TTM EBITDA is now -7.94% below its all-time high of $2.60 million, reached on June 1, 2024.
Performance
KPRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
KPRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.4% | -8.3% | +119.6% |
| 3 y3 years | -81.5% | -9.3% | +118.3% |
| 5 y5 years | -15.7% | -9.3% | +118.3% |
KPRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +11.2% | -120.4% | +52.8% | -7.9% | +117.4% |
| 5 y | 5-year | -81.5% | +11.2% | -120.4% | +52.8% | -7.9% | +117.4% |
| alltime | all time | -1015.5% | +15.0% | -120.4% | +52.8% | -7.9% | +116.5% |
Kiora Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.70 M(+11.5%) | $2.39 M(-7.9%) |
| Jun 2024 | - | -$2.42 M(-118.3%) | $2.60 M(+1.9%) |
| Mar 2024 | - | $13.21 M(-331.6%) | $2.55 M(-120.6%) |
| Dec 2023 | -$12.36 M(-9.4%) | -$5.71 M(+129.2%) | -$12.36 M(+1.1%) |
| Sep 2023 | - | -$2.49 M(+0.9%) | -$12.22 M(-6.6%) |
| Jun 2023 | - | -$2.47 M(+45.3%) | -$13.09 M(+0.8%) |
| Mar 2023 | - | -$1.70 M(-69.5%) | -$12.98 M(-4.9%) |
| Dec 2022 | -$13.65 M(-1.9%) | -$5.57 M(+66.0%) | -$13.65 M(-0.6%) |
| Sep 2022 | - | -$3.36 M(+42.2%) | -$13.73 M(+3.0%) |
| Jun 2022 | - | -$2.36 M(-0.1%) | -$13.33 M(-1.3%) |
| Mar 2022 | - | -$2.36 M(-58.2%) | -$13.50 M(+2.8%) |
| Dec 2021 | -$13.91 M(+104.2%) | -$5.65 M(+91.2%) | -$13.14 M(+52.0%) |
| Sep 2021 | - | -$2.96 M(+16.9%) | -$8.64 M(+12.5%) |
| Jun 2021 | - | -$2.53 M(+26.5%) | -$7.69 M(+11.9%) |
| Mar 2021 | - | -$2.00 M(+72.3%) | -$6.87 M(+0.8%) |
| Dec 2020 | -$6.81 M(-2.0%) | -$1.16 M(-41.9%) | -$6.81 M(-17.4%) |
| Sep 2020 | - | -$2.00 M(+17.0%) | -$8.25 M(-14.7%) |
| Jun 2020 | - | -$1.71 M(-12.2%) | -$9.66 M(-1.2%) |
| Mar 2020 | - | -$1.95 M(-25.0%) | -$9.78 M(+40.7%) |
| Dec 2019 | -$6.95 M(-35.0%) | -$2.59 M(-24.1%) | -$6.95 M(+2.4%) |
| Sep 2019 | - | -$3.42 M(+87.2%) | -$6.78 M(+4.7%) |
| Jun 2019 | - | -$1.82 M(-306.4%) | -$6.48 M(-12.8%) |
| Mar 2019 | - | $883.80 K(-136.4%) | -$7.43 M(-30.5%) |
| Dec 2018 | -$10.69 M | -$2.43 M(-22.0%) | -$10.69 M(-14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$3.11 M(+12.3%) | -$12.42 M(-7.6%) |
| Jun 2018 | - | -$2.77 M(+16.9%) | -$13.45 M(-3.9%) |
| Mar 2018 | - | -$2.37 M(-43.1%) | -$14.00 M(-3.7%) |
| Dec 2017 | -$14.54 M(+9.0%) | -$4.17 M(+0.8%) | -$14.54 M(+3.3%) |
| Sep 2017 | - | -$4.14 M(+24.5%) | -$14.07 M(+5.7%) |
| Jun 2017 | - | -$3.32 M(+14.0%) | -$13.31 M(-3.6%) |
| Mar 2017 | - | -$2.91 M(-21.1%) | -$13.81 M(+3.5%) |
| Dec 2016 | -$13.34 M(+106.7%) | -$3.70 M(+9.5%) | -$13.34 M(+8.3%) |
| Sep 2016 | - | -$3.38 M(-11.7%) | -$12.32 M(+19.7%) |
| Jun 2016 | - | -$3.82 M(+56.5%) | -$10.29 M(+28.5%) |
| Mar 2016 | - | -$2.44 M(-8.7%) | -$8.01 M(+24.2%) |
| Dec 2015 | -$6.45 M(+482.3%) | -$2.68 M(+97.7%) | -$6.45 M(+63.4%) |
| Sep 2015 | - | -$1.35 M(-12.2%) | -$3.95 M(+90.3%) |
| Jun 2015 | - | -$1.54 M(+75.0%) | -$2.08 M(+85.5%) |
| Mar 2015 | - | -$880.60 K(+406.7%) | -$1.12 M(+0.9%) |
| Dec 2014 | -$1.11 M(-63.9%) | -$173.80 K(-133.4%) | -$1.11 M(-28.5%) |
| Sep 2014 | - | $520.40 K(-189.0%) | -$1.55 M(-43.9%) |
| Jun 2014 | - | -$584.40 K(-32.8%) | -$2.76 M(-6.3%) |
| Mar 2014 | - | -$870.20 K(+41.3%) | -$2.95 M(-3.8%) |
| Dec 2013 | -$3.07 M(-47.1%) | -$615.80 K(-11.2%) | -$3.07 M(+25.1%) |
| Sep 2013 | - | -$693.60 K(-9.8%) | -$2.45 M(+39.5%) |
| Jun 2013 | - | -$769.30 K(-22.1%) | -$1.76 M(+77.9%) |
| Mar 2013 | - | -$987.10 K | -$987.10 K |
| Dec 2012 | -$5.80 M | - | - |
FAQ
- What is Kiora Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals annual EBITDA year-on-year change?
- What is Kiora Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Kiora Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Kiora Pharmaceuticals?
- What is Kiora Pharmaceuticals TTM EBITDA year-on-year change?
What is Kiora Pharmaceuticals annual EBITDA?
The current annual EBITDA of KPRX is -$12.36 M
What is the all time high annual EBITDA for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high annual EBITDA is -$1.11 M
What is Kiora Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, KPRX annual EBITDA has changed by +$1.29 M (+9.42%)
What is Kiora Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of KPRX is -$2.70 M
What is the all time high quarterly EBITDA for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high quarterly EBITDA is $13.21 M
What is Kiora Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, KPRX quarterly EBITDA has changed by -$206.60 K (-8.30%)
What is Kiora Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of KPRX is $2.39 M
What is the all time high TTM EBITDA for Kiora Pharmaceuticals?
Kiora Pharmaceuticals all-time high TTM EBITDA is $2.60 M
What is Kiora Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, KPRX TTM EBITDA has changed by +$14.62 M (+119.58%)